EFuturesCFO · Non-Profit Suite
R&D Portfolio & Capital Allocation
Evaluate R&D spend efficiency by therapeutic area. Compare risk-adjusted returns, optimize allocation, and identify high-value programs vs. candidates for pruning.
Executive Summary
Therapeutic Area Efficiency Ranking
Risk-adjusted value per $1 invested
5-Year R&D & Returns
Optimization Levers
Ranked by portfolio value impact
Executive Recommendations
Methodology
Risk-Adj Value = Peak Sales × POS × Patent Life (8yr avg) × (1 − COGS 18%). Efficiency = rNPV ÷ Spend. ROI = (rNPV − Spend) ÷ Spend. POS rates by TA from BIO/QLS industry data. Stage allocation uses pharma industry benchmarks (30% Phase III, 25% Discovery).